Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders.
Mandeep KumarNhung Thi Phuong NguyenMarco MilaneseGiambattista BonannoPublished in: Biomolecules (2022)
Most neurodegenerative disorders have complex and still unresolved pathology characterized by progressive neuronal damage and death. Astrocytes, the most-abundant non-neuronal cell population in the central nervous system, play a vital role in these processes. They are involved in various functions in the brain, such as the regulation of synapse formation, neuroinflammation, and lactate and glutamate levels. The development of human-induced pluripotent stem cells (iPSCs) reformed the research in neurodegenerative disorders allowing for the generation of disease-relevant neuronal and non-neuronal cell types that can help in disease modeling, drug screening, and, possibly, cell transplantation strategies. In the last 14 years, the differentiation of human iPSCs into astrocytes allowed for the opportunity to explore the contribution of astrocytes to neurodegenerative diseases. This review discusses the development protocols and applications of human iPSC-derived astrocytes in the most common neurodegenerative conditions.
Keyphrases
- induced pluripotent stem cells
- endothelial cells
- single cell
- cell therapy
- pluripotent stem cells
- multiple sclerosis
- traumatic brain injury
- oxidative stress
- stem cells
- high glucose
- mesenchymal stem cells
- bone marrow
- resting state
- blood brain barrier
- lps induced
- functional connectivity
- subarachnoid hemorrhage
- cerebrospinal fluid
- lipopolysaccharide induced